Mather Group LLC. Has $620,000 Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Mather Group LLC. lowered its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 17.1% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,539 shares of the company’s stock after selling 1,139 shares during the period. Mather Group LLC.’s holdings in Cardinal Health were worth $620,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of CAH. Norges Bank acquired a new stake in Cardinal Health during the fourth quarter valued at $258,499,000. Ameriprise Financial Inc. raised its stake in shares of Cardinal Health by 82.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 4,128,009 shares of the company’s stock worth $358,390,000 after purchasing an additional 1,862,291 shares in the last quarter. California Public Employees Retirement System lifted its holdings in shares of Cardinal Health by 118.9% during the 4th quarter. California Public Employees Retirement System now owns 1,516,035 shares of the company’s stock valued at $152,816,000 after buying an additional 823,520 shares during the last quarter. International Assets Investment Management LLC bought a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $464,800,000. Finally, CIBC Private Wealth Group LLC increased its holdings in Cardinal Health by 1,941.9% in the fourth quarter. CIBC Private Wealth Group LLC now owns 458,160 shares of the company’s stock worth $46,183,000 after buying an additional 435,722 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.3 %

Shares of NYSE CAH opened at $104.37 on Friday. Cardinal Health, Inc. has a 12 month low of $85.11 and a 12 month high of $116.04. The company has a market cap of $25.42 billion, a P/E ratio of 46.39, a P/E/G ratio of 1.18 and a beta of 0.64. The business’s 50 day moving average is $100.49 and its two-hundred day moving average is $104.73.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, May 2nd. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.95 by $0.13. Cardinal Health had a net margin of 0.25% and a negative return on equity of 54.74%. The business had revenue of $54.90 billion for the quarter, compared to analyst estimates of $56.05 billion. During the same quarter in the previous year, the firm posted $1.74 earnings per share. Cardinal Health’s revenue was up 8.7% compared to the same quarter last year. Sell-side analysts expect that Cardinal Health, Inc. will post 7.35 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Monday, July 1st will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Monday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.50. This represents a $2.02 dividend on an annualized basis and a yield of 1.94%. Cardinal Health’s dividend payout ratio (DPR) is 89.78%.

Wall Street Analysts Forecast Growth

CAH has been the subject of several recent research reports. Wells Fargo & Company decreased their target price on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a research report on Monday, April 29th. Leerink Partnrs reiterated an “outperform” rating on shares of Cardinal Health in a report on Monday, February 26th. SVB Leerink started coverage on Cardinal Health in a report on Monday, February 26th. They set an “outperform” rating and a $125.00 target price on the stock. Robert W. Baird decreased their price target on Cardinal Health from $134.00 to $128.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Finally, Evercore ISI increased their price objective on Cardinal Health from $110.00 to $115.00 and gave the company an “in-line” rating in a report on Friday, May 3rd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $109.67.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.